Showing 2,601 - 2,620 results of 62,107 for search '(( 5 ((step decrease) OR (we decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.26s Refine Results
  1. 2601
  2. 2602
  3. 2603
  4. 2604
  5. 2605

    Enrichment of Phosphatidylethanolamine in Viral Replication Compartments via Co-opting the Endosomal Rab5 Small GTPase by a Positive-Strand RNA Virus by Kai Xu (122914)

    Published 2016
    “…Deletion of Rab5 orthologs in a yeast model host or expression of dominant negative mutants of plant Rab5 greatly decreases TBSV replication and prevents the redistribution of PE to the sites of viral replication. …”
  6. 2606
  7. 2607
  8. 2608
  9. 2609
  10. 2610
  11. 2611
  12. 2612
  13. 2613
  14. 2614
  15. 2615

    Vanadium(V<sup>IV</sup>)–Porphyrin-Based Metal–Organic Frameworks for Synergistic Bimetallic Activation of Inert C(sp<sup>3</sup>)–H Bonds by Yefei Wang (430888)

    Published 2022
    “…Herein, by decorating vanadium­(V<sup>IV</sup>)–porphyrin into metal–organic frameworks (MOFs) to stabilize the active tertbutyl peroxide radical, we reported a new approach to accomplish inert C­(sp<sup>3</sup>)–H bond activation by a synergistic bimetallic strategy via a hydrogen atom transfer process under mild conditions. …”
  16. 2616

    Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease by Christine M. LaPash Daniels (796881)

    Published 2015
    “…Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. …”
  17. 2617
  18. 2618

    Front-of-pack nutritional labels: Understanding by low- and middle-income Mexican consumers by Jorge Vargas-Meza (7878926)

    Published 2019
    “…<div><p>Front-of-pack labeling is a cost-effective strategy to decrease population consumption of sodium, sugar, saturated fat, total fat, and trans-fatty acids, considered critical nutrients for chronic disease. …”
  19. 2619

    Differences among the classes of CAMs. by Daniel P. Bradley (10306893)

    Published 2025
    “…Some <i>N</i>-hydroxypyridinedione (HPD) HBV RNaseH inhibitors significantly reduced accumulation of capsids in HBV-replicating cells. A representative HPD <b>1466</b>, with a 50% effective concentration against HBV replication of 0.25 µM, decreased capsid and core protein accumulation by 50–90% in HepDES19 and HepG2.2.15 cells. …”
  20. 2620